157 related articles for article (PubMed ID: 24195302)
21. Inflammatory bowel disease in the dog: differences and similarities with humans.
Cerquetella M; Spaterna A; Laus F; Tesei B; Rossi G; Antonelli E; Villanacci V; Bassotti G
World J Gastroenterol; 2010 Mar; 16(9):1050-6. PubMed ID: 20205273
[TBL] [Abstract][Full Text] [Related]
22. Plasma amino acid profiles in dogs with inflammatory bowel disease.
Tamura Y; Ohta H; Kagawa Y; Osuga T; Morishita K; Sasaki N; Takiguchi M
J Vet Intern Med; 2019 Jul; 33(4):1602-1607. PubMed ID: 31111561
[TBL] [Abstract][Full Text] [Related]
23. Alteration of the fecal microbiota and serum metabolite profiles in dogs with idiopathic inflammatory bowel disease.
Minamoto Y; Otoni CC; Steelman SM; Büyükleblebici O; Steiner JM; Jergens AE; Suchodolski JS
Gut Microbes; 2015; 6(1):33-47. PubMed ID: 25531678
[TBL] [Abstract][Full Text] [Related]
24. A scoring index for disease activity in canine inflammatory bowel disease.
Jergens AE; Schreiner CA; Frank DE; Niyo Y; Ahrens FE; Eckersall PD; Benson TJ; Evans R
J Vet Intern Med; 2003; 17(3):291-7. PubMed ID: 12774968
[TBL] [Abstract][Full Text] [Related]
25. Reduced diversity of immunoglobulin and T-cell receptor gene rearrangements in chronic inflammatory gastrointestinal diseases in dogs.
Olivero D; Turba ME; Gentilini F
Vet Immunol Immunopathol; 2011 Dec; 144(3-4):337-45. PubMed ID: 21908056
[TBL] [Abstract][Full Text] [Related]
26. Canine breeds at high risk of developing inflammatory bowel disease in the south-eastern UK.
Kathrani A; Werling D; Allenspach K
Vet Rec; 2011 Dec; 169(24):635. PubMed ID: 21896567
[TBL] [Abstract][Full Text] [Related]
27. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.
Sidler MA; Leach ST; Day AS
Inflamm Bowel Dis; 2008 Mar; 14(3):359-66. PubMed ID: 18050298
[TBL] [Abstract][Full Text] [Related]
28. The effect of budesonide on the expression of Ki-67 and PCNA and the apoptotic index in dogs with inflammatory bowel disease.
Szweda M; Rychlik A; Nowicki M; Kaczmar E
Pol J Vet Sci; 2017 Dec; 20(4):743-750. PubMed ID: 29611642
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory bowel disease affects density of nitrergic nerve fibers in the mucosal layer of the canine gastrointestinal tract.
Rychlik A; Gonkowski S; Nowicki M; Calka J
Can J Vet Res; 2017 Apr; 81(2):129-136. PubMed ID: 28408781
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of disease activity markers in dogs with idiopathic inflammatory bowel disease.
McCann TM; Ridyard AE; Else RW; Simpson JW
J Small Anim Pract; 2007 Nov; 48(11):620-5. PubMed ID: 17608662
[TBL] [Abstract][Full Text] [Related]
31. [Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease].
Münster M; Hörauf A; Bilzer T
Berl Munch Tierarztl Wochenschr; 2006; 119(11-12):493-505. PubMed ID: 17172138
[TBL] [Abstract][Full Text] [Related]
32. Association between nucleotide oligomerisation domain two (Nod2) gene polymorphisms and canine inflammatory bowel disease.
Kathrani A; Lee H; White C; Catchpole B; Murphy A; German A; Werling D; Allenspach K
Vet Immunol Immunopathol; 2014 Sep; 161(1-2):32-41. PubMed ID: 25017709
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory bowel disease in veterinary medicine.
Jergens AE; Simpson KW
Front Biosci (Elite Ed); 2012 Jan; 4(4):1404-19. PubMed ID: 22201965
[TBL] [Abstract][Full Text] [Related]
34. Methylation of TNFRSF13B and TNFRSF13C in duodenal mucosa in canine inflammatory bowel disease and its association with decreased mucosal IgA expression.
Maeda S; Ohno K; Fujiwara-Igarashi A; Tomiyasu H; Fujino Y; Tsujimoto H
Vet Immunol Immunopathol; 2014 Jul; 160(1-2):97-106. PubMed ID: 24814046
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of endoscopic examination for the diagnosis of inflammatory bowel disease in the dog.
Rychlik A; Nieradka R; Kander M; Depta A; Nowicki M; Sarti K
Pol J Vet Sci; 2007; 10(2):113-8. PubMed ID: 17882936
[TBL] [Abstract][Full Text] [Related]
36. Assessment of eosinophil peroxidase as a potential diagnostic and prognostic marker in dogs with inflammatory bowel disease.
Bastan I; Robinson NA; Ge XN; Rendahl AK; Rao SP; Washabau RJ; Sriramarao P
Am J Vet Res; 2017 Jan; 78(1):36-41. PubMed ID: 28029282
[TBL] [Abstract][Full Text] [Related]
37. Oral chondroitin sulfate and prebiotics for the treatment of canine Inflammatory Bowel Disease: a randomized, controlled clinical trial.
Segarra S; Martínez-Subiela S; Cerdà-Cuéllar M; Martínez-Puig D; Muñoz-Prieto A; Rodríguez-Franco F; Rodríguez-Bertos A; Allenspach K; Velasco A; Cerón J
BMC Vet Res; 2016 Mar; 12():49. PubMed ID: 26965834
[TBL] [Abstract][Full Text] [Related]
38. What are the potential biomarkers that should be considered in diagnosing and managing canine chronic inflammatory enteropathies?
Sacoor C; Barros LM; Montezinho L
Open Vet J; 2021 Jan; 10(4):412-430. PubMed ID: 33614437
[TBL] [Abstract][Full Text] [Related]
39. Fecal microbiome in dogs with inflammatory bowel disease and intestinal lymphoma.
Omori M; Maeda S; Igarashi H; Ohno K; Sakai K; Yonezawa T; Horigome A; Odamaki T; Matsuki N
J Vet Med Sci; 2017 Nov; 79(11):1840-1847. PubMed ID: 28993566
[TBL] [Abstract][Full Text] [Related]
40. Utility of the combined use of 3 serologic markers in the diagnosis and monitoring of chronic enteropathies in dogs.
Estruch J; Johnson J; Ford S; Yoshimoto S; Mills T; Bergman P
J Vet Intern Med; 2021 May; 35(3):1306-1315. PubMed ID: 33960552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
